KSHV manipulation of the cell cycle and apoptosis

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 540-558

  Moore, Patrick S ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862557052     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.031     Document Type: Chapter

References (161)

1. Bais, C., Santomasso, B., Coso, O. et al. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature, 391(6662), 86-89.
2. Bakhshi, A., Jensen, J. P., Goldman, P. et al. (1985). Cloning the chro-mosomal breakpoint of t(14;18) human lymphomas: Cluster-ing around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 41(3), 899-906.
3. Banin, S., Moyal, L., Shieh, S. et al. (1998). Enhanced phosphory-lation of p53 by ATM in response to DNA damage. Science, 281(5383), 1674-1677.
4. Barozzi, P., Luppi, M., Facchetti, F. et al. (2003). Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat. Med., 9(5), 554-561.
5. Bellows, D. S., Chau, B. N., Lee, P., Lazebnik, Y., Burns, W. H., and Hardwick, J. M. (2000). Antiapoptotic herpesvirus bcl-2 homologs escape caspase-mediated conversion to proapop-totic proteins. J. Virol., 74(11), 5024-5031.
6. Benedict, C. A., Norris, P. S., and Ware, C. F. (2002). To kill or be killed: Viral evasion of apoptosis. Nat. Immunol., 3(11), 1013-1018.
7. Bieleski, L., Hindley, C., and Talbot, S. J. (2004). A polypyrimidine tract facilitates the expression of Kaposi's sarcoma-associated herpesvirus vFLIP through an internal ribosome entry site. J. Gen. Virol., 85(3), 615-620.
8. Bieleski, L. and Talbot, S. J. (2001). Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site. J. Virol., 75(4), 1864-1869.
9. Borah, S., Verma, S. C., and Robertson, E. S. (2004). ORF73 of Herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor sup-pressor proteins p53 and pRb. J. Virol., 78(19), 10336-10347.
10. Boshoff, C., Endo, Y., Collins, P. D. et al. (1997). Angiogenic and HIV inhibitory functions of KSHV-encoded chemokines. Science, 278, 290-294.
11. Braithwaite, A. W. and Russell, I. A. (2001). Induction of cell death by adenoviruses. Apoptosis, 6(5), 359-370.
12. Burger, R., Neipel, F., Fleckenstein, B. et al. (1998). Human her-pesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood, 91(6), 1858-1863.
13. Cai, X. and Cullen, B. R. (2006). Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs, J. Virol., 80(5), 2234-2242.
14. Cai, X., Lu, S., Zhang, Z., Gonzalez, C. M., Damania, B., and Cullen, B. R. (2005). Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells, Proc. Natl. Acad. Sci. USA, 102(15), 5570-5575.
15. Cannon, M., Philpott, N. J., and Cesarman, E. (2003). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J. Virol., 77(1), 57-67.
16. Cesarman, E., Nador, R. G., Bai, F. et al. (1996). Kaposi's sarcoma-associated herpesvirus contains G protein-coupled recep-tor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol., 70(11), 8218-8223.
17. Cesarman, E., Mesri, E. A., and Gershengorn, M. C. (2000). Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? [comment]. J. Exp. Med., 191(3), 417-422.
18. Chatterjee, M., Osborne, J., Bestetti, G., Chang, Y., and Moore, P. S. (2002). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science, 298(5597), 1432-1435.
19. Chaudhary, P. M., Jasmin, A., Eby, M. T., and Hood, L. (1999). Modu-lation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene, 18(42), 5738-5746.
20. Cheng, E. H., Nicholas, J., Bellows, D. S. et al. (1997). A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl Acad. Sci. USA, 94(2), 690-694.
21. Cheng, E. H., Wei, M. C., Weiler, S. et al. (2001). BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis. Mol. Cell, 8(3), 705-711.
22. Child, E. S. and Mann, D. J. (2001). Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from qui-escence, Oncogene, 20(26), 3311-3322.
23. Chiou, C. J., Poole, L. J., Kim, P. S. et al. (2002). Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol., 76(7), 3421-3439.
24. Chow, D.-C., He, X.-L., Snow, A. L., Rose-John, S., and Garcia, K. C. (2001). Structure of an extracellular gp130 cytokine receptor signaling complex. Science, 291(5511), 2150-2155.
25. Coscoy, L. and Ganem, D. (2000). Kaposi's sarcoma-associated her-pesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl Acad. Sci. USA, 97(14), 8051-8056.
26. Cuconati, A. and White, E. (2002). Viral homologs of BCL-2: Role of apoptosis in the regulation of virus infection. Genes Dev., 16(19), 2465-2478.
27. Dairaghi, D. J., Fan, R. A., McMaster, B. E., Hanley, M. R., and Schall, T. J. (1999). HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist pro?les of viral chemokines. J. Biol. Chem., 274(31), 21569-21574.
28. Damania, B., Choi, J. K., and Jung, J. U. (2000). Signaling activities of gammaherpesvirus membrane proteins. J. Virol., 74(4), 1593-1601.
29. Danial, N. N. and Korsmeyer, S. J. (2004). Cell death: Critical control points, Cell, 116(2), 205-219.
30. de Stanchina, E., McCurrach, M. E., Zindy, F. et al. (1998). E1A sig-naling to p53 involves the p19(ARF) tumor suppressor, Genes Dev., 12(15), 2434-2442.
31. Debbas, M. and White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7, 546-554.
32. Djerbi, M., Screpanti, V., Catrina, A. I., Bogen, B., Biberfeld, P., and Grandien, A. (1999). The inhibitor of death receptor signaling, FLICE-inhibitory protein de?nes a new class of tumor progres-sion factors, J. Exp. Med., 190(7), 1025-1032.
33. Ellis, M., Chew, Y. P., Fallis, L. et al. (1999). Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex, EMBO J., 18(3), 644-653.
34. Endres, M. J., Garlisi, C. G., Xiao, H., Shan, L., and Hedrick, J. A. (1999). The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a speci?c agonist for the CC chemokine receptor (CCR)8. J. Exp. Med., 189(12), 1993-1998.
35. Feng, P., Park, J., Lee, B. S., Lee, S. H., Bram, R. J., and Jung, J. U. (2002). Kaposi's sarcoma-associated herpesvirus mitochon-drial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J. Virol., 76(22), 11491-11504.
36. Feng, P., Scott, C. W., Cho, N. H. et al. (2004). Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to pro-mote protein degradation. Mol. Cell. Biol., 24(9), 3938-3948.
37. Field, N., Low, W., Daniels, M. et al. (2003). KSHV vFLIP binds to IKK-gamma to activate IKK, J. Cell. Sci., 116(18), 3721-3728.
38. Fraser, A. and James, C. (1998). Fermenting debate: Do yeast undergo apoptosis? Trends Cell. Biol., 8(6), 219-221.
39. Friborg, J., Jr., Kong, W., Hottiger, M. O., and Nabel, G. J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature, 402(6764), 889-894.
40. Fujimuro, M. and Hayward, S. D. (2003). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J. Virol., 77(14), 8019-8030.
41. Fujimuro, M., Wu, F. Y., ApRhys, C. et al. (2003). A novel viral mech-anism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med., 9(3), 300-306.
42. Gao, S.-J., Boshoff, C., Jayachandra, S., Weiss, R. A., Chang, Y., and Moore, P. S. (1997). KSHV ORF K9 (vIRF) is an oncogene that inhibits the interferon signaling pathway. Oncogene, 15, 1979-1986.
43. Glaunsinger, B. and Ganem, D. (2004). Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell., 13(5), 713-723.
44. Godden-Kent, D., Talbot, S. J., Boshoff, C. et al. (1997). The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimu-lates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol., 71(6), 4193-4198.
45. Gorospe, M., Cirielli, C., Wang, X., Seth, P., Capogrossi, M. C., and Holbrook, N. J. (1997). p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene, 14(8), 929-935.
46. Gruffat, H., Portes-Sentis, S., Sergeant, A., and Manet, E. (1999). Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1. J. Gen. Virol., 80(3), 557-561.
47. Grundhoff, A. and Ganem, D. (2001). Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J. Virol., 75(4), 1857-1863.
48. Guasparri, I., Keller, S. A., and Cesarman, E. (2004). KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med., 199(7), 993-1003.
49. Guo, H. G., Sadowska, M., Reid, W., Tschachler, E., Hayward, G., and Reitz, M. (2003). Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J. Virol., 77(4), 2631-2639.
50. Gwack, Y., Byun, H., Hwang, S., Lim, C., and Choe, J. (2001a). CREB-binding protein and histone deacetylase regulate the tran-scriptionalactivityof Kaposi'ssarcoma-associatedherpesvirus open reading frame 50. J. Virol., 75(4), 1909-1917.
51. Gwack, Y., Hwang, S., Byun, H. et al. (2001b). Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J. Virol., 75(13), 6245-6248.
52. Hayward, S. D., Liu, J., and Fujimuro, M. (2006). Notch and Wnt sig-naling: Mimicry and manipulation by gamma herpesviruses, Sci. STKE, 2006(335), re4.
53. Hobeika, A. C., Subramaniam, P. S., and Johnson, H. M. (1997). IFNcx induces the expression of the cyclin-dependent kinase inhibitorp21 inhumanprostatecancercells. Oncogene, 14(10), 1165-1170.
54. Holst, P. J., Rosenkilde, M. M., Manfra, D. etal.(2001). Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J. Clin. Invest., 108(12), 1789-1796.
55. Huang, Q., Petros, A. M., Virgin, H. W., Fesik, S. W., and Olejniczak, E. T. (2002). Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc. Natl Acad. Sci. USA, 99(6), 3428-3433.
56. Hwang, S., Gwack, Y., Byun, H., Lim, C., and Choe, J. (2001). The Kaposi's sarcoma-associated herpesvirus K8 protein inter-acts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J. Virol., 75(19), 9509-9516.
57. Izumiya, Y., Lin, S. F., Ellison, T. J. etal.(2003). Cellcycleregulationby Kaposi's sarcoma-associated herpesvirus K-bZIP: Direct inter-action with cyclin-CDK2 and induction of G1 growth arrest. J. Virol., 77(17), 9652-9661.
58. Jeffrey, P. D., Tong, L., and Pavletich, N. P. (2000). Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev., 14(24), 3115-3125.
59. Jeong, J. H., Orvis, J., Kim, J. W., McMurtrey, C. P., Renne, R., and Dittmer, D. P. (2004). Regulation and autoregulation of the pro-moter for the latency-associated nuclear antigen of Kaposi's Sarcoma-associated herpesvirus. J. Biol. chem., 279, 16822-16831.
60. Jones, K. D., Aoki, Y., Chang, Y., Moore, P. S., Yarchoan, R., and Tosato, G. (1999). Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood, 94(8), 2871-2879.
61. Judde, J. G., Lacoste, V., Briere, J. et al. (2000). Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J. Natl Can-cer Inst., 92(9), 729-736.
62. Kaldis, P., Ojala, P. M., Tong, L., Makela, T. P., and Solomon, M. J. (2001). CAK-independent activation of CDK6 by a viral cyclin, Mol. Biol. Cell, 12(12), 3987-3999.
63. Katano, H., Ogawa-Goto, K., Hasegawa, H., Kurata, T., and Sata, T. (2001a). Human-herpesvirus-8-encoded K8 protein colo-calizes with the promyelocytic leukemia protein (PML) bod-ies and recruits p53 to the PML bodies. Virology, 286(2), 446-455.
64. Katano, H., Sato, Y., and Sata, T. (2001b). Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies. Cancer, 92(12), 3076-3084.
65. Keller, S. A., Schattner, E. J., and Cesarman, E. (2000). Inhibition of NF-kappa B induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 96(7), 2537-2542.
66. Kirshner, J. R., Staskus, K., Haase, A., Lagunoff, M., and Ganem, D. (1999). Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: Implications for KS pathogenesis. J. Virol., 73(7), 6006-6014.
67. Klotzbucher, A., Stewart, E., Harrison, D., and Hunt, T. (1996). The 'destruction box' of cyclin A allows B-type cyclins to be ubiq-uitinated, but not ef?ciently destroyed. EMBO J., 15(12), 3053-3064.
68. Kozar, K., Ciemerych, M. A., Rebel, V. I. et al. (2004). Mouse devel-opment and cell proliferation in the absence of D-cyclins. Cell, 118(4), 477-491.
69. Krishnan, H. H., Naranatt, P. P., Smith, M. S., Zeng, L., Bloomer, C., and Chandran, B. (2004). Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and ?broblast cells and subsequent decline of lytic gene expres-sion. J. Virol., 78(7), 3601-3620.
70. Krueger, A., Baumann, S., Krammer, P. H., and Kirchhoff, S. (2001). FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis. Mol. Biol. Cell, 21(24), 8247-8254.
71. Lagunoff, M. and Carroll, P. A. (2003). Inhibition of apoptosis by the gamma-herpesviruses. Int. Rev. Immunol., 22(5-6), 373-399.
72. Lagunoff, M., Majeti, R., Weiss, A., and Ganem, D. (1999). Deregu-lated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Natl Acad. Sci. USA, 96(10), 5704-5709.
73. Lagunoff, M., Lukac, D. M., and Ganem, D. (2001). Immunorecep-tor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: Effects on lytic viral replication. J. Virol., 75(13), 5891-5898.
74. Laman, H., Coverley, D., Krude, T., Laskey, R., and Jones, N. (2001). Viral cyclin-cyclin-dependent kinase 6 complexes ini-tiate nuclear DNA replication. Mol. Cell Biol., 21(2), 624-635.
75. Lan, K., Choudhuri, T., Murakami, M., Kuppers, D. A., and Robert-son, E. S. (2006). Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro, J. Virol., 80(13), 6411-6419.
76. Lane, D. P. (1992). p53, guardian of the genome. Nature, 358(6381), 15-16.
77. Lee, B. S., Alvarez, X., Ishido, S., Lackner, A. A., and Jung, J. U. (2000). Inhibition of intracellular transport of B cell antigen recep-tor complexes by Kaposi's sarcoma-associated herpesvirus K1. J. Exp. Med., 192(1), 11-21.
78. Lee, B. S., Connole, M., Tang, Z., Harris, N. L., and Jung, J. U. (2003). Structural analysis of the Kaposi's sarcoma-associated her-pesvirus K1 protein. J. Virol., 77(14), 8072-8086.
79. Lee, H., Guo, J., Li, M. et al. (1998a). Identification of an immunore-ceptor tyrosine-based activation motif of K1 transforming pro-tein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol., 18(9), 5219-5228.
80. Lee, H., Veazey, R., Williams, K. et al. (1998b). Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated her-pesvirus. Nat. Med., 4(4), 435-440.
81. Lee, J. H. and Paull, T. T. (2004). Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science, 304.(5667), 93-96.
82. Li, M., Lee, H., Yoon, D. W. et al. (1997). Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol., 71(3), 1984-1991.
83. Li, M., Damania, B., Alvarez, X., Ogryzko, V., Ozato, K., and Jung, J. U. (2000). Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol. Cell. Biol., 20(21), 8254-8263.
84. Liang, C., Feng, P., Ku, B., Dotan, I., Canaani, D., Oh, B. H., and Jung, J. U. (2006). Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG, Nat. Cell. Biol., 8(7), 688-699.
85. Lin, S. F., Robinson, D. R., Miller, G., and Kung, H. J. (1999). Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J. Virol., 73(3), 1909-1917.
86. Lin, R., Genin, P., Mamane, Y. et al. (2001). HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene, 20(7), 800-811.
87. Liu, L., Eby, M. T., Rathore, N., Sinha, S. K., Kumar, A., and Chaud-hary, P. M. (2002). The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and per-sistently activates the Ikappa B kinase complex. J. Biol. Chem., 277(16), 13745-13751.
88. Low, W., Harries, M., Ye, H., Du, M. Q., Boshoff, C., and Collins, M. (2001). Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein. J. Virol., 75(6), 2938-2945.
89. Lubyova, B., Kellum, M. J., Frisancho, A. J., and Pitha, P. M. (2004). Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7, J. Biol. Chem., 279(9), pp. 7643-7654.
90. Mann, D. J., Child, E. S., Swanton, C., Laman, H., and Jones, N. (1999). Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO J., 18(3), 654-663.
91. Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., and Robinson, C. A. (1999). Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N. Engl. J. Med., 340(14), 1063-1070.
92. Masood, R., Cesarman, E., Smith, D. L., Gill, P. S., and Flore, O. (2002). Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth fac-tor/vascular endothelial growth factor receptor. Am. J. Pathol., 160(1), 23-29.
93. Matta, H. and Chaudhary, P. M. (2004). Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc. Natl Acad. Sci. USA, 101(25), 9399-9404.
94. Meinl, E., Fickenscher, H., Thome, M., Tschopp, J., and Fleck-enstein, B. (1998). Anti-apoptotic strategies of lymphotropic viruses. Immunol. Today, 19(10), 474-479.
95. Mittnacht, S. and Boshoff, C. (2000). Viral cyclins. Rev. Med. Virol., 10(3), 175-184.
96. Molden, J., Chang, Y., You, Y., Moore, P. S., and Goldsmith, M. A. (1997). A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit, J. Biol. Chem., 272(31), 19625-19631.
97. Montaner, S., Sodhi, A., Pece, S., Mesri, E. A., and Gutkind, J. S. (2001). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res., 61(6), 2641-2648.
98. Montaner, S., Sodhi, A., Molinolo, A. et al. (2003). Endothelial infection with KSHV genes in vivo reveals that vGPCR initi-ates Kaposi's sarcomagenesis and can promote the tumori-genic potential of viral latent genes. Cancer Cell, 3(1), 23-36.
99. Moore, P. S. (2003). Transplanting cancer: Donor-cell transmission of Kaposi sarcoma. Nat. Med., 9(5), 506-508.
100. Moore, P. S. and Chang, Y. (1998). Antiviral activity of tumor-suppressor pathways: Clues from molecular piracy by KSHV. Trends Genet., 14(4), 144-150.
101. Moore, P. S. and Chang, Y. (2001). Molecular virology of Kaposi's sarcoma-associated herpesvirus. Phil. Trans. R. Soc. Lond. B Biol. Sci., 356(1408), 499-516.
102. Moore, P. S. and Chang, Y. (2003). Kaposi's sarcoma-associated her-pesvirus immunoevasion and tumorigenesis: Two sides of the same coin? Annu. Rev. Microbiol., 57, 609-639.
103. Moore, P. S., Boshoff, C., Weiss, R. A., and Chang, Y. (1996). Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science, 274(5293), 1739-1744.
104. Mullberg, J., Geib, T., Jostock, T. et al. (2000). IL-6 receptor indepen-dent stimulation of human gp130 by viral IL-6. J. Immunol., 164(9), 4672-4677.
105. Murray, A. W. (2004). Recycling the cell cycle: Cyclins revisited, Cell, 116(2), 221-234.
106. Nakamura, H., Li, M., Zarycki, J., and Jung, J. U. (2001). Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J. Virol., 75(16), 7572-7582.
107. Nicholas, J., Ruvolo, V. R., Burns, W. H. et al. (1997). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage in?ammatory protein-1 and interleukin-6. Nat. Med., 3(3), 287-292.
108. Oda, E., Ohki, R., Murasawa, H. (2000). Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288(5468), 1053-1058.
109. Ojala, P. M., Yamamoto, K., Castanos-Velez, E., Biberfeld, P., Korsmeyer, S. J., and Makela, T. P. (2000). The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell. Biol., 2(11), 819-825.
110. Osborne, J., Moore, P. S., and Chang, Y. (1999). KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum. Immunol., 60(10), 921-927.
111. Park, J., Seo, T., Hwang, S., Lee, D., Gwack, Y., and Choe, J. (2000). The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J. Virol., 74(24), 11977-11982.
112. Parravicini, C., Corbellino, M. Paulli, M. et al. (1997). Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am. J. Pathol., 151(6), 1517-1522.
113. Parravicini, C., Chandran, B., Corbellino, M. et al. (2000). Differ-ential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effu-sion lymphoma, and multicentric Castleman's disease. Am. J. Pathol., 156(3), 743-749.
114. Polson, A. G., Huang, L., Lukac, D. M. et al. (2001). Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol., 75(7), 3175-3140.
115. Polson, A. G., Wang, D., DeRisi, J., and Ganem, D.(2002). Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. Cancer Res., 62(15), 4525-4530.
116. Radkov, S. A., Kellam, P., and Boshoff, C. (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene hras transforms primary rat cells. Nat. Med., 6(10), 1121-1127.
117. Rivas, C., Thlick, A. E., Parravicini, C., Moore, P. S., and Chang, Y. (2001). Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-speci?c latent viral protein that inhibits p53. J. Virol., 75(1), 429-438.
118. Russell, I. A., Royds, J. A., and Braithwaite, A. W. (2004). Exploitation of cell cycle and cell death controls by adenoviruses: The road to a productive infection. Prog. Mol. Subcell Biol., 36, 207-243.
119. Russo, J. J., Bohenzky, R. A., Chien, M. C. et al. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl Acad. Sci. USA, 93(25), 14862-14867.
120. Sangfelt, O., Erickson, S., Einhorn, S., and Grander, D. (1997). Induc-tion of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines. Oncogene, 14(4), 415-423.
121. Sarid, R., Sato, T., Bohenzky, R. A., Russo, J. J., and Chang, Y. (1997). Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat. Med., 3(3), 293-298.
122. Sarid, R., Wiezorek, J. S., Moore, P. S., and Chang, Y. (1999). Char-acterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J. Virol., 73(2), 1438-1446.
123. Schuler, M. and Green, D. R. (2001). Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans., 29(6), 684-688.
124. Seaman, W. T., Ye, D., Wang, R. X., Hale, E. E., Weisse, M., and Quin-livan, E. B. (1999). Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology, 263(2), 436-449.
125. Schmid, D., Dengjel, J., Schoor, O., Stevanovic, S., and Munz, C. (2006). Autophagy in innate and adaptive immunity against intracellular pathogens, J. Mol. Med., 84(3), 194-202.
126. Seo, T., Park, J., Lim, C., and Choe, J. (2004). Inhibition of nuclear factor kappa B activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus, Oncogene, 23(36), pp. 6146-6155.
127. Sheard, M. A., Uldrijan, S., and Vojtesek, B. (2003). Role of p53 in reg-ulating constitutive and X-radiation-inducible CD95 expres-sion and function in carcinoma cells. Cancer Res., 63(21), 7176-7184.
128. Sherr, C. J. (1998). Tumor surveillance via the ARF-p53 pathway Genes Dev., 12(19), 2984-2991.
129. Sherr, C. J. (2004). Principles of tumor suppression. Cell, 116(2), 235-246.
130. Shin, Y. C., Nakamura, H., Liang, X., Feng, P., Chang, H., Kowalik, T. F., and Jung, J. U. (2006). Inhibition of the ATM/p53 signal trans-duction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1, J. Virol., 80(5), 2257-2266.
131. Stine, J. T., Wood, C., Hill, M. et al. (2000). KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogene-sis, and selectively chemoattracts TH2 cells. Blood, 95(4), 1151-1157.
132. Sun, R., Lin, S. F., Staskus, K. et al. (1999). Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol., 73(3), 2232-2242.
133. Swanton, C., Mann, D. J., Fleckenstein, B., Neipel, F., Peters, G., and Jones, N. (1997). Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature, 390(6656), 184-187.
134. Swanton, C., Card, G. L., Mann, D., McDonald, N., and Jones, N. (1999). Overcoming inhibitions: Subversion of CKI function by viral cyclins. Trends Biochem. Sci., 24(3), 116-120.
135. Takaoka, A., Hayakawa, S., Yanai, H. et al. (2003). Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature, 424(6948), 516-523.
136. Teodoro, J. G. and Branton, P. E. (1997). Regulation of apoptosis by viral gene products. J. Virol., 71, 1739-1746.
137. Tomescu, C., Law, W. K., and Kedes, D. H. (2003). Surface downreg-ulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J. Virol., 77(17), 9669-9684.
138. Tomita, M., Choe, J., Tsukazaki, T., and Mori, N. (2004). The Kaposi's Sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein. Oncogene, 23, 8272-8281.
139. Tomlinson, C. C. and Damania, B. (2004). The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J. Virol., 78(4), 1918-1927.
140. Urashima, M., Ogata, A., Chauhan, D. et al. (1996). Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood, 88(6), 2219-2227.
141. Urashima, M., Teoh, G., Chauhan, D. et al. (1997). Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells. Blood, 90(1), 279-289.
142. Van Dross, R., Yao, S., Asad, S., Westlake, G., Mays, D. J., Bar-quero, L., Duell, S., Pietenpol, J. A., and Browning, P. J. (2005). Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells, J. Natl. Cancer Inst., 97(9), 656-666.
143. Verma, S. C., Borah, S., and Robertson, E. S. (2004). Latency-associated nuclear antigen of kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with tran-scription factor Sp1. J. Virol., 78(19), 10348-10359.
144. Verschuren, E. W., Hodgson, J. G., Gray, J. W., Kogan, S., Jones, N., and Evan, G. I. (2004a). The role of p53 in suppression of KSHV cyclin-inducedlymphomagenesis. Cancer Res., 64(2), 581-589.
145. Verschuren, E. W., Jones, N., and Evan, G. I. (2004b). The cell cycle and how it is steered by Kaposi's sarcoma-associated her-pesvirus cyclin. J. Gen. Virol., 85(6), 1347-1361.
146. Verschuren, E. W., Klefstrom, J., Evan, G. I., and Jones, N. (2002). The oncogenic potential of Kaposi's sarcoma-associated her-pesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell, 2(3), 229-241.
147. Wang, L., Dittmer, D. P., Tomlinson, C. C., Fakhari, F. D., and Dama-nia, B. (2006). Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus, Cancer Res., 66(7), 3658-3666.
148. Wang, H. W., Sharp, T. V., Koumi, A., Koentges, G., and Boshoff, C. (2002). Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resemblesasplicedvariantofhumansurvivin. EMBOJ., 21(11), 2602-2615.
149. Wang, L., Wakisaka, N., Tomlinson, C. C. et al. (2004). The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Can-cer Res., 64(8), 2774-2781.
150. Wang, S. E., Wu, F. Y., Fujimuro, M., Zong, J., Hayward, S. D., and Hayward, G. S. (2003a). Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP, J. Virol., 77(1), 600-623.
151. Wang, S. E., Wu, F. Y., Yu, Y., and Hayward, G. S. (2003b). CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters, J. Virol., 77(17), 9590-9612.
152. Weitzman, M. D., Carson, C. T., Schwartz, R. A., and Lil-ley, C. E. (2004). Interactions of viruses with the cellular DNA repair machinery, DNA Repair (Amst), 3(8-9), 1165-1173.
153. Widmer, I., Wernli, M., Bachmann, F., Gudat, F., Cathomas, G., and Erb, P. (2002). Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions. J. Virol., 76(5), 2551-2556.
154. Wood, R. D., Mitchell, M., Sgouros, J., and Lindahl, T. (2001). Human DNA repair genes. Science, 291(5507), 1284-1289.
155. Wu, K. J., Grandori, C., Amacker, M. et al. (1999). Direct activation of TERT transcription by c-MYC. Nat. Genet., 21(2), 220-224.
156. Wu, F. Y., Wang, S. E., Tang, Q. Q. et al. (2003). Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1). J. Virol., 77(16), 8893-8914.
157. Yang, B. T., Chen, S. C., Leach, M. W. et al. (2000). Transgenic expression of the chemokine receptor encoded by human her-pesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med., 191(3), 445-454.
158. Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., and Vogelstein, B. (2001). PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell, 7(3), 673-682.
159. Zhu, Y. M., Bradbury, D. A., Keith, F. J., and Russell, N. (1994). Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia, 8(11), 1982-1988.
160. Zimring, J. C., Goodbourn, S., and Offermann, M. K. (1998). Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol., 72(1), 701-707.
161. Zindy, F., Eischen, C. M., Randle, D. H. et al. (1998). Myc signal-ing via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 12(15), 2424-2433.